DOCSLIB.ORG

Case of the Anti HIV-1 Antibody, B12

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Case of the Anti HIV-1 Antibody, B12 Spectrum of Somatic Hypermutations and Implication on Antibody Function: Case of the anti HIV-1 antibody, b12 Mesfin Mulugeta Gewe A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2015 Reading Committee: Roland Strong, Chair Nancy Maizels Jessica A. Hamerman Program Authorized to Offer Degree: Molecular and Cellular Biology i ii ©Copyright 2015 Mesfin Mulugeta Gewe iii University of Washington Abstract Spectrum of Somatic Hypermutations and Implication on Antibody Function: Case of the anti HIV-1 antibody, b12 Mesfin Mulugeta Gewe Chair of the Supervisory Committee: Roland Strong, Full Member Fred Hutchinson Cancer Research Center Sequence diversity, ability to evade immune detection and establishment of human immunodeficiency virus type 1 (HIV-1) latent reservoirs present a formidable challenge to the development of an HIV-1 vaccine. Structure based vaccine design stenciled on infection elicited broadly neutralizing antibodies (bNAbs) is a promising approach, in some measure to circumvent existing challenges. Understanding the antibody maturation process and importance of the high frequency mutations observed in anti-HIV-1 broadly neutralizing antibodies are imperative to the success of structure based vaccine immunogen design. Here we report a biochemical and structural characterization for the affinity maturation of infection elicited neutralizing antibodies IgG1 b12 (b12). We investigated the importance of affinity maturation and mutations accumulated therein in overall antibody function and their potential implications to vaccine development. Using a panel of point iv reversions, we examined relevance of individual amino acid mutations acquired during the affinity maturation process to deduce the role of somatic hypermutation in antibody function. Biophysical characterizations of b12 point mutant interactions with gp120 monomers from two Clade B viruses (SF162 and QH0692) indicates importance of cooperative contributions by individual mutations accumulated due to the extensive maturation processes in attaining the observed broadly neutralizing properties of b12. However, effects of individual mutations on epitope binding do not correlate with their effect on virus neutralization potency. Establishment of viral latent reservoirs, rendering antibody-based immune responses ineffective as preventive treatments, precedes serum detections of infection elicited highly potent bNAbs. Bearing the goal of structure based vaccine immunogen design that recapitulate b12-like immune response, we also investigated the minimum mutations on germline antibody sequences required to garner b12 comparable epitope binding affinity and virus neutralization potency. Our progressive increase in mutations on germline b12 precursor antibody approach reveled the importance of mutations on both antibody complementarity determining (CDR) and framework regions (FWR) in epitope binding and virus neutralization. Here we report extensive mutations and prolonged affinity maturation are vital to the development of highly potent bNAbs. One potential mechanism in attaining increased affinity maturation following the antibody maturation process is conformational antibody rearrangement and rigidification of antibody variable domains. To determine the role of extensive antibody mutations in the overall antibody structural flexibility and conformational rearrangements, we examined the structures of germline precursor b12 light chain variable domains. Accordingly, our structural analyses reveal absence of apparent effect on global structure of antibody light chain variable domains following affinity maturation. However, local structural affects are observed where germline precursor antibody CDRs exhibited conformational samplings distinct from b12 light chain CDRs. While germline precursor antibody CDRs sample different conformations, the process of antibody maturation focused the epitope binding region to specific conformation enabling high affinity epitope binding. v These data suggest that structure based vaccine development that utilize b12-like bNAbs as templet need to develop a scheme that enables extensive affinity maturation observed in bNAbs. The bodies of work presented here, representing work on multiple aspects of bNAb development, potentially highlight key basic science research on HIV vaccinology that inform HIV vaccine development. vi Dedication To my wife Genet Tadesse and daughter Tinsae Mesfin for enduring the headwinds and to my parents Mulugeta Gewe and Fetlework Bekele for believing in me. vii Table of Content Abstract ........................................................................................................................................................ iv Dedication ................................................................................................................................................... vii Table of Content ........................................................................................................................................ viii List of Table .................................................................................................................................................. x List of Figures ............................................................................................................................................... x Chapter 1: ...................................................................................................................................................... 1 1.1 Introduction ................................................................................................................................................... 1 1.2 HIV-1 and antibody based immunity ............................................................................................................. 5 1.3 The antibody development paradigm.......................................................................................................... 10 1.4 The HIV vaccine design paradox ................................................................................................................ 13 1.5 Documents presented in this Thesis ........................................................................................................... 16 Chapter 2 ..................................................................................................................................................... 18 2.1 Overview ..................................................................................................................................................... 18 2.2 Results ........................................................................................................................................................ 21 2.2.1 Amino Acid Sequence Analysis of b12 Mature and Germline Precursor ................................................ 21 2.2.2 Characterization of b12 c/scFvs proteins ............................................................................................... 24 2.2.3 Epitope binding is affected by SHM on CDRs more than FWRs ............................................................ 28 2.2.4 Individual mSRs exhibit minimal effect on virus neutralization potency .................................................. 31 2.2.5 SHM on CDR micro satellites exhibit correlated effect on epitope binding and virus neutralization ....... 32 2.3 Discussion .................................................................................................................................................. 36 2.3.1 Structural implication of antibody light chain .......................................................................................... 39 2.4 Acknowledgment ........................................................................................................................................ 42 Chapter 3 ..................................................................................................................................................... 43 3.1 Overview ..................................................................................................................................................... 43 3.2 Results ........................................................................................................................................................ 45 3.2.1 gRBs for progressive SHM analysis ....................................................................................................... 45 3.2.2 b12 comparable binding kinetics necessitate extensive mutation of germline encoded precursor antibodies.............................................................................................................................................................. 49 3.2.3 Mature b12 comparable neutralization potency does not correlate with binding affinity. ........................ 51 3.3 Discussion .................................................................................................................................................. 56 3.4 Acknowledgment ........................................................................................................................................ 57 Chapter 4 ..................................................................................................................................................... 58 4.1 Overview ....................................................................................................................................................
Load more

Recommended publications
  • NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development
    Review NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development Calum Forrest 1 , Ariane Gomes 1 , Matthew Reeves 1,* and Victoria Male 2,* 1 Institute of Immunity & Transplantation, UCL, Royal Free Campus, London NW3 2PF, UK; [email protected] (C.F.); [email protected] (A.G.) 2 Department of Metabolism, Digestion and Reproduction, Imperial College London, Chelsea and Westminster Campus, London SW10 9NH, UK * Correspondence: [email protected] (M.R.); [email protected] (V.M.) Received: 24 June 2020; Accepted: 15 July 2020; Published: 20 July 2020 Abstract: Natural killer (NK) cells are innate lymphoid cells that recognize and eliminate virally-infected and cancerous cells. Members of the innate immune system are not usually considered to mediate immune memory, but over the past decade evidence has emerged that NK cells can do this in several contexts. Of these, the best understood and most widely accepted is the response to cytomegaloviruses, with strong evidence for memory to murine cytomegalovirus (MCMV) and several lines of evidence suggesting that the same is likely to be true of human cytomegalovirus (HCMV). The importance of NK cells in the context of HCMV infection is underscored by the armory of NK immune evasion genes encoded by HCMV aimed at subverting the NK cell immune response. As such, ongoing studies that have utilized HCMV to investigate NK cell diversity and function have proven instructive. Here, we discuss our current understanding of NK cell memory to viral infection with a focus on the response to cytomegaloviruses. We will then discuss the implications that this will have for the development of a vaccine against HCMV with particular emphasis on how a strategy that can harness the innate immune system and NK cells could be crucial for the development of a vaccine against this high-priority pathogen.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • The T Cell Repertoire Specific for the IE-1 Protein of Human Cytomegalovirus: Diversity, Function and Evasion
    Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München The T cell repertoire specific for the IE-1 protein of human cytomegalovirus: diversity, function and evasion von Stefanie Maria Ameres aus Deggendorf, Deutschland 2012 Erklärung Diese Dissertation wurde im Sinne von §7 der Promotionsordnung vom 28. November 2011 von Herrn Prof. Dr. Wolfgang Hammerschmidt betreut und von Herrn Prof. Dr. Horst Domdey vor der Fakultät für Chemie und Pharmazie vertreten. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, den 03.07.2012 Stefanie Ameres Dissertation eingereicht am 03.07.2012 1. Gutachter: Prof. Dr. Horst Domdey 2. Gutachter: Prof. Dr. Wolfgang Hammerschmidt Mündliche Prüfung am 28.01.2013 Teile dieser Arbeit werden/wurden wie folgt veröffentlicht: Ameres, S., J. Mautner, F. Schlott, M. Neuenhahn, D.H. Busch, B. Plachter, and A. Moosmann. Antigen Presentation to an Immunodominant Population of HLA-C-Restricted T Cells Resists Cytomegalovirus Immunoevasion. 2nd revision PLOS Pathogens Hesse, J., S. Ameres, K. Besold, S. Krauter, A. Moosmann, and B. Plachter. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection. Epub oct 2012. J. Gen. Virol. Teile dieser Arbeit wurden im Rahmen der Dissertation wie folgt präsentiert: May 3rd–4th, 2012 DFG SFB-TR36 Symposium "Adoptive T Cell Therapy" Berlin, Germany Talk: "CD8+ T cells overcome HCMV immunoevasion dependent on their HLA restriction" Dec. 5th–7th, 2011 DFG SFB-TR36 Retreat "Principles and Applications of Wildbad Kreuth, Adoptive T Cell therapy" Germany Talk: "CD8+ T cells defeat HCMV immunoevasins dependent on MHC restriction" May 14th–17th, 2011 13th International CMV/Betaherpesvirus Workshop Nürnberg, Germany Poster 1: "Preferential T cell control of HCMV infection through HLA-C" Poster 2: "HCMV IE-1 is recognized by a diverse repertoire of CD4+ Tcells" Oct.
    [Show full text]
  • T-Cell Receptor
    T-cell receptor The T-cell receptor (TCR) is a protein complex found on the surface of T cells, or T lymphocytes,[1] that is responsible for recognizing fragments of antigen as peptides bound to major histocompatibility complex (MHC) molecules. The binding between TCR and antigen peptides is of relatively low affinity and is degenerate: that is, many TCRs recognize the same antigen peptide and many antigen peptides are recognized by the same TCR.[2] The TCR is composed of two different protein chains (that is, it is a hetero dimer). In humans, in 95% of T cells the TCR consists of an The T-cell receptor complex with alpha (α) chain and a beta (β) chain (encoded by TRA and TRB, TCR-α and TCR-β chains, CD3 and ζ- respectively), whereas in 5% of T cells the TCR consists of gamma chain accessory molecules. and delta (γ/δ) chains (encoded by TRG and TRD, respectively). Identifiers This ratio changes during ontogeny and in diseased states (such as leukemia). It also differs between species. Orthologues of the 4 loci Symbol TCR_zetazeta have been mapped in various species.[3][4] Each locus can produce Pfam PF11628 (http://pfa a variety of polypeptides with constant and variable regions.[3] m.xfam.org/family?ac c=PF11628) When the TCR engages with antigenic peptide and MHC (peptide/MHC), the T lymphocyte is activated through signal InterPro IPR021663 (https://w transduction, that is, a series of biochemical events mediated by ww.ebi.ac.uk/interpro/ associated enzymes, co-receptors, specialized adaptor molecules, entry/IPR021663) and activated or released transcription factors.
    [Show full text]
  • Structural Basis of Mouse Cytomegalovirus M152/Gp40 Interaction with Rae1γ Reveals a Paradigm for MHC/MHC Interaction in Immune
    Structural basis of mouse cytomegalovirus m152/gp40 PNAS PLUS interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion Rui Wanga, Kannan Natarajana, Maria Jamela R. Revillezaa, Lisa F. Boyda, Li Zhia,1, Huaying Zhaob, Howard Robinsonc, and David H. Marguliesa,2 aMolecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; bDynamics of Macromolecular Assembly Section, Laboratory of Cellular Imaging and Macromolecular Biophysics, National Institute of Biomolecular Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892; and cNational Synchrotron Light Source, Brookhaven National Laboratories, Upton, NY 11973 Edited by K. Christopher Garcia, Stanford University, Stanford, CA, and approved October 24, 2012 (received for review August 17, 2012) Natural killer (NK) cells are activated by engagement of the NKG2D NKG2D ligands, we examined the binding of the MCMV m152 receptor with ligands on target cells stressed by infection or glycoprotein to its RAE1 ligands. Our previous studies investigated tumorigenesis. Several human and rodent cytomegalovirus (CMV) the quantitative interaction of m152 with different RAE1 isoforms immunoevasins down-regulate surface expression of NKG2D (21). Here we report the X-ray structure of the complex of m152 ligands. The mouse CMV MHC class I (MHC-I)–like m152/gp40 glyco- with RAE1γ, the confirmation of the intermolecular contacts protein down-regulates retinoic acid early inducible-1 (RAE1) observed in the crystal structure by site-directed mutagenesis and NKG2D ligands as well as host MHC-I. Here we describe the crystal in vitro binding assays, a comparison of the binding of m152 to structure of an m152/RAE1γ complex and confirm the intermolec- RAE1 and of NKG2D to RAE1, and the functional effects of ular contacts by mutagenesis.
    [Show full text]
  • Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for A
    International Journal of Molecular Sciences Article Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01 Se-Young Lee 1,†, Deok-Han Ko 1,†, Min-Jeong Son 1, Jeong-Ah Kim 1, Keunok Jung 2 and Yong-Sung Kim 1,2,* 1 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea; [email protected] (S.-Y.L.); [email protected] (D.-H.K.); [email protected] (M.-J.S.); [email protected] (J.-A.K.) 2 Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon 16499, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-31-219-2662; Fax: +82-31-219-1610 † These authors have contributed equally to this work. Abstract: Human cytomegalovirus (CMV) infection is widespread among adults (60–90%) and is usually undetected in healthy individuals without symptoms but can cause severe diseases in im- munocompromised hosts. T-cell receptor (TCR)-like antibodies (Abs), which recognize complex antigens (peptide–MHC complex, pMHC) composed of MHC molecules with embedded short pep- tides derived from intracellular proteins, including pathogenic viral proteins, can serve as diagnostic and/or therapeutic agents. In this study, we aimed to engineer a TCR-like Ab specific for pMHC comprising a CMV pp65 protein-derived peptide (495NLVPMVATV503; hereafter, CMVpp65 ) 495-503 in complex with MHC-I molecule human leukocyte antigen (HLA)-A*02:01 (CMVpp65495-503/HLA- A*02:01) to increase affinity by sequential mutagenesis of complementarity-determining regions Citation: Lee, S.-Y.; Ko, D.-H.; Son, M.-J.; Kim, J.-A.; Jung, K.; Kim, Y.-S.
    [Show full text]
  • What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination?: a Role for Antibody Feedback
    Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? A Role for Antibody Feedback Kai-Michael Toellner,1 Daniel M.-Y. Sze,2 and Yang Zhang1 1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, United Kingdom 2School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia Correspondence: [email protected] We discuss the impact of antibody feedback on affinity maturation of B cells. Competition from epitope-specific antibodies produced earlier during the immune response leads to immune complex formation, which is essential for transport and deposition of antigen onto follicular dendritic cells (FDCs). It also reduces the concentration of free epitopes into the mM to nM range, which is essential for B-cell receptors (BCRs) to sense affinity-dependent changes in binding capacity. Antibody feedback may also induce epitope spreading, leading to a broader selection of epitopes recognized by newly emerging B-cell clones. This may be exploitable, providing ways to manipulate epitope usage induced by vaccination. GREAT DEBATES What are the most interesting topics likely to come up over dinner or drinks with your colleagues? Or, more importantly, what are the topics that don’t come up because they are a little too controversial? In Immune Memory and Vaccines: Great Debates, Editors Rafi Ahmed and Shane Crotty have put together a collection of articles on such ques- tions, written by thought leaders in these fields, with the freedom to talk about the issues as they see fit.
    [Show full text]
  • Nurse Shark T-Cell Receptors Employ Somatic Hyper- Mutation Preferentially to Alter Alpha/Delta Variable Segments Associated with Alpha Constant Region
    Eur. J. Immunol. 2020. 50: 1307–1320 DOI: 10.1002/eji.201948495 Jeannine A. Ott et al. 1307 Basic Adaptive immunity Research Article Nurse shark T-cell receptors employ somatic hyper- mutation preferentially to alter alpha/delta variable segments associated with alpha constant region Jeannine A. Ott1 , Jenna Harrison1, Martin F. Flajnik2 and Michael F. Criscitiello1,3 1 Comparative Immunogenetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA 2 Department of Microbiology and Immunology, School of Medicine, University of Maryland at Baltimore, Baltimore, MD, USA 3 Department of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA In addition to canonical TCR and BCR, cartilaginous fish assemble noncanonical TCR that employ various B-cell components. For example, shark T cells associate alpha (TCR- α) or delta (TCR-δ) constant (C) regions with Ig heavy chain (H) variable (V) segments or TCR-associated Ig-like V (TAILV) segments to form chimeric IgV-TCR, and combine TCRδC with both Ig-like and TCR-like V segments to form the doubly rearranging NAR- TCR. Activation-induced (cytidine) deaminase-catalyzed somatic hypermutation (SHM), typically used for B-cell affinity maturation, also is used by TCR-α during selection in the shark thymus presumably to salvage failing receptors. Here, we found that the use of SHM by nurse shark TCR varies depending on the particular V segment or C region used. First, SHM significantly alters alpha/delta V (TCRαδV) segments using TCR αC but not δC.
    [Show full text]
  • The Murine Cytomegalovirus Immunoevasin Gp40 Binds MHC
    © 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 219-227 doi:10.1242/jcs.175620 RESEARCH ARTICLE The murine cytomegalovirus immunoevasin gp40 binds MHC class I molecules to retain them in the early secretory pathway Linda Janßen1, Venkat Raman Ramnarayan1, Mohamed Aboelmagd1, Maro Iliopoulou1, Zeynep Hein1, Irina Majoul2, Susanne Fritzsche1, Anne Halenius3 and Sebastian Springer1,* ABSTRACT ERGIC or cis-Golgi, and we demonstrate that a sequence in the In the presence of the murine cytomegalovirus (mCMV) gp40 (m152) linker between the folded lumenal domain of gp40 and the protein, murine major histocompatibility complex (MHC) class I transmembrane sequence is required for this retention. molecules do not reach the cell surface but are retained in an early compartment of the secretory pathway. We find that gp40 does not RESULTS impair the folding or high-affinity peptide binding of the class I Gp40 retains MHC class I in the early secretory pathway molecules but binds to them, leading to their retention in the To assess the effect of gp40 on murine class I molecules, we m152 endoplasmic reticulum (ER), the ER-Golgi intermediate compartment expressed in K41 cells (murine fibroblasts) by lentiviral (ERGIC) and the cis-Golgi, most likely by retrieval from the cis-Golgi to transduction. The surface levels of the endogenous class I allotypes b b b b the ER. We identify a sequence in gp40 that is required for both its own H-2D (D ) and H-2K (K ) were reduced to background levels in retention in the early secretory pathway and for that of class I most cells, as observed by flow cytometry with the allotype-specific β b molecules.
    [Show full text]
  • Epstein-Barr Virus May Contribute to Central Nervous System Involvement in HIV-Positive Individuals
    bioRxiv preprint doi: https://doi.org/10.1101/341354; this version posted June 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Epstein-Barr Virus May Contribute to Central Nervous System Involvement in HIV-positive 2 Individuals 3 Lupia T1#*, Milia MG2, Atzori C3, Audagnotto S1, Imperiale D3, Mighetto L4, Pirriatore V1, Gregori G2, 4 Lipani F1, Ghisetti V2, Bonora S1, Di Perri G1, Calcagno A1. 5 1 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy 6 2 Laboratory of Virology and Molecular Biology, Ospedale Amedeo di Savoia, ASL “Città di Torino”, 7 Torino, Italy 8 3 Unit of Neurology, Ospedale Maria Vittoria, ASL “Città di Torino”, Torino, Italy 9 4 Laboratory of Immunology, Ospedale Maria Vittoria, ASL “Città di Torino”, Torino, Italy. 10 11 Running Head: EBV and HIV in the CSF 12 13 14 #Address correspondence to Tommaso Lupia, [email protected] 15 *Present address: Tommaso Lupia, Unit of Infectious Diseases, Department of Medical Sciences, 16 University of Torino, Amedeo di Savoia Hospital, C.so Svizzera 164, 10149 Torino, Italy 17 18 19 20 Type of article: Original article 21 22 Key words: EBV; HIV; central nervous system; blood brain barrier; trafficking; biomarkers; S-100 23 beta. 24 25 Word count: Total 2097 (Abstract 250) 26 27 Figures: 3 28 29 Tables: 2 30 31 32 Conflicts of Interest and Source of Funding: AC has received honoraria from Abbvie, BMS, Gilead, 33 Janssen-Cilag, MSD, Viiv and he is currently receiving research grants from BMS, Gilead and Viiv.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]
  • B-Cell Development, Activation, and Differentiation
    B-Cell Development, Activation, and Differentiation Sarah Holstein, MD, PhD Nov 13, 2014 Lymphoid tissues • Primary – Bone marrow – Thymus • Secondary – Lymph nodes – Spleen – Tonsils – Lymphoid tissue within GI and respiratory tracts Overview of B cell development • B cells are generated in the bone marrow • Takes 1-2 weeks to develop from hematopoietic stem cells to mature B cells • Sequence of expression of cell surface receptor and adhesion molecules which allows for differentiation of B cells, proliferation at various stages, and movement within the bone marrow microenvironment • Immature B cell leaves the bone marrow and undergoes further differentiation • Immune system must create a repertoire of receptors capable of recognizing a large array of antigens while at the same time eliminating self-reactive B cells Overview of B cell development • Early B cell development constitutes the steps that lead to B cell commitment and expression of surface immunoglobulin, production of mature B cells • Mature B cells leave the bone marrow and migrate to secondary lymphoid tissues • B cells then interact with exogenous antigen and/or T helper cells = antigen- dependent phase Overview of B cells Hematopoiesis • Hematopoietic stem cells (HSCs) source of all blood cells • Blood-forming cells first found in the yolk sac (primarily primitive rbc production) • HSCs arise in distal aorta ~3-4 weeks • HSCs migrate to the liver (primary site of hematopoiesis after 6 wks gestation) • Bone marrow hematopoiesis starts ~5 months of gestation Role of bone
    [Show full text]